Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,938.96
1,622.06
1,032.29
642.04
643.00
566.87
371.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,938.96
1,622.06
1,032.29
642.04
643.00
566.87
371.00
Raw Material Cost
803.12
583.45
457.06
312.27
315.58
269.73
197.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
354.31
290.45
209.28
134.49
124.66
100.99
82.33
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
66.18
35.10
16.42
9.44
6.28
12.59
7.84
Selling and Distribution Expenses
387.61
345.04
251.04
170.00
134.27
101.39
73.41
Other Expenses
-19.62
-12.80
-12.01
-8.15
-7.39
-6.03
-5.01
Total Expenditure (Excl Depreciation)
1,415.04
1,126.05
813.73
544.74
506.89
424.37
311.38
Operating Profit (PBDIT) excl Other Income
523.9
496
218.6
97.30000000000001
136.1
142.5
59.6
Other Income
-7.59
23.29
5.57
62.90
13.95
28.10
8.42
Operating Profit (PBDIT)
754.05
693.42
329.45
239.25
222.17
236.57
106.70
Interest
66.18
35.10
16.42
9.44
6.28
12.59
7.84
Exceptional Items
1.91
-2.79
0.26
-1.96
-1.15
-0.30
0.89
Gross Profit (PBDT)
1,135.84
1,038.61
575.23
329.77
327.42
297.14
173.06
Depreciation
329.29
217.03
140.16
104.68
89.02
77.12
46.34
Profit Before Tax
360.49
438.50
173.13
123.16
125.73
146.56
53.41
Tax
35.08
38.69
7.67
0.39
16.92
26.53
8.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
332.42
404.39
162.94
129.11
115.39
123.44
48.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
332.42
404.39
162.94
129.11
115.39
123.44
48.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-7.01
-4.57
2.52
-6.34
-6.58
-3.41
-3.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
325.41
399.82
165.45
122.77
108.81
120.03
44.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,985.57
2,656.47
2,170.27
1,910.23
1,811.38
963.34
834.29
Earnings per share (EPS)
1.06
1.31
0.55
0.43
0.39
0.41
0.16
Diluted Earnings per share
1.06
1.31
0.55
0.43
0.39
0.41
0.16
Operating Profit Margin (Excl OI)
22.3%
27.93%
17.8%
11.16%
18.54%
23.17%
14.0%
Gross Profit Margin
35.57%
40.41%
30.35%
35.49%
33.4%
39.46%
26.89%
PAT Margin
17.14%
24.93%
15.78%
20.11%
17.95%
21.78%
13.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 19.54% vs 57.13% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -18.61% vs 141.57% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 13.65% vs 106.88% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 88.60% vs 114.02% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Sinopep-Allsino Bio Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,938.96
0
1,938.96
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,938.96
0
1,938.96
Raw Material Cost
803.12
0
803.12
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
354.31
0
354.31
Power Cost
0
0
0.00
Manufacturing Expenses
66.18
0
66.18
Selling and Distribution Expenses
387.61
0
387.61
Other Expenses
-19.62
0.00
-19.62
Total Expenditure (Excl Depreciation)
1,415.04
0
1,415.04
Operating Profit (PBDIT) excl Other Income
523.93
0.00
523.93
Other Income
-7.59
0
-7.59
Operating Profit (PBDIT)
754.05
0
754.05
Interest
66.18
0
66.18
Exceptional Items
1.91
0
1.91
Gross Profit (PBDT)
1,135.84
0
1,135.84
Depreciation
329.29
0
329.29
Profit Before Tax
360.49
0
360.49
Tax
35.08
0
35.08
Provisions and contingencies
0
0
0.00
Profit After Tax
332.42
0
332.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
332.42
0
332.42
Share in Profit of Associates
0
0
0.00
Minority Interest
-7.01
0
-7.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
325.41
0
325.41
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,985.57
0
2,985.57
Earnings per share (EPS)
1.06
0
1.06
Diluted Earnings per share
1.06
0
1.06
Operating Profit Margin (Excl OI)
22.30%
0%
0.00
22.30%
Gross Profit Margin
35.57%
0%
0.00
35.57%
PAT Margin
17.14%
0%
0.00
17.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 193.90 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 19.54% vs 57.13% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 32.54 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -18.61% vs 141.57% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 76.16 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 13.65% vs 106.88% in Dec 2024
Annual - Interest
Interest 6.62 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 88.60% vs 114.02% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.30%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






